Efficacy and Safety of Bimekizumab in Moderate to Severe Hidradenitis Suppurativa-Reference-Cited by-同舟云学术

Efficacy and Safety of Bimekizumab in Moderate to Severe Hidradenitis Suppurativa

Published:2021-11-01 Issue:11 Volume:157 Page:1279
ISSN:2168-6068
Container-title:JAMA Dermatology
language:en
Short-container-title:JAMA Dermatol

Author:

Glatt Sophie¹,Jemec Gregor B. E.²³,Forman Seth⁴,Sayed Christopher⁵,Schmieder George⁶,Weisman Jamie⁷,Rolleri Robert⁸,Seegobin Seth¹,Baeten Dominique¹,Ionescu Lucian⁹,Zouboulis Christos C.¹⁰,Shaw Stevan¹

Affiliation:

1. UCB Pharma, Slough, United Kingdom

2. Department of Dermatology, Zealand University Hospital, Roskilde

3. Health Sciences Faculty, University of Copenhagen, Copenhagen, Denmark

4. ForCare Clinical Research, Tampa, Florida

5. Department of Dermatology, University of North Carolina School of Medicine, Chapel Hill

6. Park Avenue Dermatology, Orange Park, Florida

7. Medical Dermatology Specialists Inc, Atlanta, Georgia

8. UCB Pharma, Raleigh, North Carolina

9. UCB Pharma, Brussels, Belgium

10. Departments of Dermatology, Venereology, Allergology and Immunology, Dessau Medical Center, Brandenburg Medical School Theodor Fontane, Dessau, Germany

Publisher

American Medical Association (AMA)

Subject

Dermatology

Link

https://jamanetwork.com/journals/jamadermatology/articlepdf/2782805/jamadermatology_glatt_2021_oi_210042_1636039123.07222.pdf

Reference41 articles.

1. Clinical practice: hidradenitis suppurativa.;Jemec;N Engl J Med,2012

2. European S1 guideline for the treatment of hidradenitis suppurativa/acne inversa.;Zouboulis;J Eur Acad Dermatol Venereol,2015

3. Epidemiology of hidradenitis suppurativa in Germany—an observational cohort study based on a multisource approach.;Kirsten;J Eur Acad Dermatol Venereol,2020

4. The natural history of hidradenitis suppurativa.;von der Werth;J Eur Acad Dermatol Venereol,2000

5. Hidradenitis suppurativa.;Danby;Dermatol Clin,2010

Cited by 108 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Report of successful treatment of follicular occlusion triad with adalimumab and research progress on biologic therapy for follicular occlusion triad;Journal of Dermatological Treatment;2024-09-09

2. Hidradenitis Suppurativa in Elderly Patients: Clinical and Therapeutical Outcomes—A Review of the Literature;Medicina;2024-09-06

3. Injection site reactions resulting from the use of biological therapy in the treatment of moderate-to-severe plaque psoriasis;Expert Opinion on Drug Safety;2024-08-17

4. Hidradenitis Suppurativa: New Targets and Emerging Treatments;American Journal of Clinical Dermatology;2024-07-26

5. Guidelines How to Integrate Surgery and Targeted Therapy with Biologics for the Treatment of Hidradenitis Suppurativa: Delphi Consensus Statements from an Italian Expert Panel;Dermatology;2024-07-18